{"title":"Using the genotype selection interface: a clinical case study for CYP2C19.","authors":"Crystal Dodson, Dorothy Dulko","doi":"10.1097/JXX.0000000000001140","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Pharmacogenetic testing is a rapidly evolving field that aims to improve the efficacy and safety of drugs by finding genetic links influencing how drugs are processed, their effectiveness, and toxicity. Due to the high incidence of adverse drug reactions (ADRs) associated with certain medications and the heterogeneity of drug responses among patients, pharmacogenetic testing has gained significant attention. Research has shown that many clinicians, including nurse practitioners (NPs), have limited knowledge and experience with pharmacogenomics and pharmacogenetic testing, highlighting the need for enhanced education in this area. Using pharmacogenetic information, NP can tailor medication regimens to personalize treatments to individual genetic profiles to improve results and reduce ADRs. This paper will apply the Genotype Selection Interface for pharmacogenetic testing and discuss its clinical application, including challenges, limitations, and future directions.</p>","PeriodicalId":17179,"journal":{"name":"Journal of the American Association of Nurse Practitioners","volume":" ","pages":"422-426"},"PeriodicalIF":1.6000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Association of Nurse Practitioners","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JXX.0000000000001140","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract: Pharmacogenetic testing is a rapidly evolving field that aims to improve the efficacy and safety of drugs by finding genetic links influencing how drugs are processed, their effectiveness, and toxicity. Due to the high incidence of adverse drug reactions (ADRs) associated with certain medications and the heterogeneity of drug responses among patients, pharmacogenetic testing has gained significant attention. Research has shown that many clinicians, including nurse practitioners (NPs), have limited knowledge and experience with pharmacogenomics and pharmacogenetic testing, highlighting the need for enhanced education in this area. Using pharmacogenetic information, NP can tailor medication regimens to personalize treatments to individual genetic profiles to improve results and reduce ADRs. This paper will apply the Genotype Selection Interface for pharmacogenetic testing and discuss its clinical application, including challenges, limitations, and future directions.
期刊介绍：
The Journal of the American Association of Nurse Practitioners (JAANP) is a monthly peer-reviewed professional journal that serves as the official publication of the American Association of Nurse Practitioners.
Published since 1989, the JAANP provides a strong clinical focus with articles related to primary, secondary, and tertiary care, nurse practitioner education, health policy, ethics and ethical issues, and health care delivery. The journal publishes original research, integrative/comprehensive reviews, case studies, a variety of topics in clinical practice, and theory-based articles related to patient and professional education. Although the majority of nurse practitioners function in primary care, there is an increasing focus on the provision of care across all types of systems from acute to long-term care settings.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
